Diligence memo · auto-generated · as of July 3, 2026

Avitus Orthopaedics, Inc.

Avitus Orthopaedics, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Avitus Orthopaedics, Inc. operates in Other Health Care, based in SHELTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Avitus Orthopaedics, Inc. has raised $7.8M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $5.0M on 2021-08-27.

Most recent recorded round closed around 2021-08-27.

Valuation (modeled)modeled

Provath models Avitus Orthopaedics, Inc. at approximately $67M (range $6.4M–$278M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.66× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 17 months.

Last raise 4.8 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 4.5× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 72% of Other Health Care peers (5377 compared).

Modeled value ranks above 71% of those peers.

Closest niche peers: InvestCo Tabletop, LLC, Mediphore, Inc., iVinci Partners, LLC, Oklahoma Proton Center LLC, MicroOptx, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.